Photo courtesy of UF | The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
The term “molecular glue degraders” may sound like the next K-pop band, but inside the lab of biochemist Thomas Kodadek, Ph.D., scientists are rocking MGDs for a serious purpose: finding treatment options for people with incurable diseases, including aggressive cancers and brain diseases.
Their goal is to exploit cells’ own internal recycling systems to address these otherwise “undruggable” diseases. A new grant from Europe is accelerating that work.
Kodadek’s team at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology recently won a worldwide competition to collaborate with the research and development department of the health care company Merck KGaA, Darmstadt, Germany.
Read more about Grant Glues Together Research Experts To Tackle Incurable Diseases.
